Navigation Links
Bionovo to Present Recent Findings of BZL101, Its Anti-cancer,Agent, at the American Association of Cancer Research

EMERYVILLE, Calif., April 16, 2007 /PRNewswire-FirstCall/ -- Bionovo, Inc. will present findings on the mechanism of action of its anti-cancer agent BZL101, which is advancing to Phase 1/2 clinical testing for late stage breast cancer at the American Association of Cancer Research (AACR) being held at the Los Angeles Convention Center in Los Angeles, CA, April 14 - 17, 2007.

Bionovo's poster presentation will describe the pathway for cancer cell apoptosis (cell death) induced by BZL101 while leaving normal cells unaffected. As explained by Dr. Emma Shtivelman, Director of Cancer Research at Bionovo, the ability of BZL101 to induce apoptosis is due to attenuation of mitochondrial transmembrane potential (MTP) leading to the release of reactive oxygen species, causing inhibition of glycolysis and ending with induction of oxidative DNA damage.

A paper on BZL101's mechanism of action and unique selective properties based on the company's initial Phase 1 clinical trial was published late last year in the peer-reviewed journal, Breast Cancer Research and Treatment.

"BZL101's mechanism of action and unique selective properties" said Dr. Isaac Cohen, President and CEO of Bionovo, "are a result of some of the biological differences between cancer cells and normal cells. We are hoping that capitalizing on the difference will result in a safe and effective treatment for cancer."

Bionovo, Inc.

Bionovo is a drug development company focusing on the discovery of novel pharmaceutical agents for cancer and women's health. The company has two drugs in clinical testing. MF101 is in Phase 2 for quality of life conditions associated with menopause, and BZL101 is in Phase 1/2 for the treatment of advanced breast cancer. The company has an additional pipeline of drugs in development for breast cancer, pancreatic cancer and other menopausal symptoms with a total of 4 drug candidates expected to be in
'"/>




Page: 1 2 3

Related medicine technology :

1. Bionovos MF101 Shows Positive Safety, Tolerability and Efficacy in Phase 2 Trial
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
Post Your Comments:
(Date:7/31/2014)... , July 31, 2014 Touro University ... has been selected as the recipient of a $150,000 ... will allow the University to increase research and classroom ... creating state-of-the-art technology for the study of health sciences, ... the diverse needs and interests of our students," said ...
(Date:7/31/2014)... SAN FRANCISCO , July 31, 2014 /PRNewswire/ ... ) and Aspira Scientific ( Milpitas, California ... joint venture to develop and commercialize new fluorination ... biologically active molecules has benefited from the use ... metabolism, and combine lipophilicity with polarity to improve ...
(Date:7/31/2014)... ANTWERP, Belgium and LONDON , July ... Organization (CRO) and services provider for the medical industries, announced today ... The United Kingdom has one ... valued at USD 8.9 billion in 2012 and it is projected ... was estimated at USD 234 billion in 2012, equal to 9.5% ...
Breaking Medicine Technology:Touro University California Garners Grant From Long Foundation 2Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2genae Opens Offices in London 2
... 22, 2011 MedVantx, Inc., today announced the deployment ... medication and adherence reporting engine across its ... in the Company,s integrated program of initial free medication ... program utilizes the Company,s proprietary automated ATM like sample ...
... NEW YORK, Nov. 22, 2011 ... research report is available in its ... - Global Pipeline Analysis, Competitive Landscape ... http://www.reportlinker.com/p0685953/MRI-Systems---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging ...
Cached Medicine Technology:MedVantx Launches Patient Profile™, A Proprietary Closed-Loop Pharmaceutical Adherence Management Program for Medical Home, Accountable Care and Population Health Management 2MedVantx Launches Patient Profile™, A Proprietary Closed-Loop Pharmaceutical Adherence Management Program for Medical Home, Accountable Care and Population Health Management 3MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12
(Date:7/31/2014)... THURSDAY, July 31, 2014 (HealthDay News) -- Transplant ... are red flags for burnout, a new study ... in the study reported having a low sense ... admitted to feeling emotionally exhausted, researchers found. ... specialties like transplantation," study co-author Dr. Marwan Abouljoud, ...
(Date:7/31/2014)... N.Y. (PRWEB) July 31, 2014 Joseph ... of the Hudson Valley (CDHV), a leading provider of ... the lower Hudson Valley. Dr. Lee is a ... cardiac electrophysiology. , In addition to his position ... at the New York-Presbyterian Hospital/ Columbia University Medical Center. ...
(Date:7/31/2014)... 31, 2014 Women in the Los ... of their financial future. The Independent Woman , ... registration for 6 upcoming Los Angeles area events. ... and with input from Kim Kiyosaki, a successful investor, ... Time) who is passionate about women’s financial education. , ...
(Date:7/31/2014)... rising steadily in the U.S in recent years. According ... the number of individuals reporting past year heroin use ... evidence suggests the increase may be linked to prescription ... PO use to heroin use, with POs providing the ... This drug-use trajectory appears to have become increasingly ...
(Date:7/31/2014)... Jersey (PRWEB) July 31, 2014 Clifton ... administer the application of topical fluoride treatments to their ... caries and help with tooth sensitivity in patients that ... is an infection that is commonly known as “tooth ... hard tissues of the teeth. , Fluoride ...
Breaking Medicine News(10 mins):Health News:Burnout Common Among Transplant Surgeons, Study Reveals 2Health News:ColumbiaDoctors of the Hudson Valley Welcomes Joseph M. Lee, M.D., M.S., R.P.V.I. 2Health News:ColumbiaDoctors of the Hudson Valley Welcomes Joseph M. Lee, M.D., M.S., R.P.V.I. 3Health News:The Independent Woman to Offer Financial Workshops in the Los Angeles Area - Developed by Women for Women 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 3Health News:NJ Top Dentists Approved, Clifton Dental Associates Now Actively Recommending the Application of Topical Fluoride Treatments to Adults 2
... in the United States will contract a sexually transmitted ... and Prevention. Experts believe a major contributing factor is ... and routinely. Now a new study provides some insight ... among teenagers. , Researchers from the Bradley ...
... Professional Postgraduate Services® (PPS®), renowned for its award-winning healthcare ... RSV and pediatric influenza, Preventing and Managing RSV Disease ... on PediatricRespiratory.org. , ... ...
... company, is thrilled to be included in Inc.,s 27th ... in the country. As the fastest growing company in ... to other healthcare staffing firms making the list it ... traveling healthcare staffing companies. It is the only company ...
... Universal,Health Services, Inc. (NYSE: UHS ) ... to sell Central Montgomery Medical Center, a 125 ... Abington Memorial,Hospital. The sale is subject to customary ... later this fall., UHS also announced that ...
... PITTSBURGH, Sept. 8 Mylan Inc. (NYSE: ... to market and other,conditions, $400 million principal amount ... offering to qualified institutional buyers pursuant,to Rule 144A ... (the "Securities,Act"). Mylan also expects to grant the ...
... spasms are a severe and potentially devastating epilepsy condition ... study appearing in Epilepsia, researchers have found ... diet more traditionally used for intractable childhood epilepsy, is ... The study is the first description of the ketogenic ...
Cached Medicine News:Health News:Teens' failure to use condoms linked to partner disapproval, fear of less sexual pleasure 2Health News:PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza 2Health News:PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza 3Health News:PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza 4Health News:Medical Solutions Ranks No. 472 in the 2008 Inc. 500 with Three-Year Sales Growth of 667.8% 2Health News:Medical Solutions Ranks No. 472 in the 2008 Inc. 500 with Three-Year Sales Growth of 667.8% 3Health News:Medical Solutions Ranks No. 472 in the 2008 Inc. 500 with Three-Year Sales Growth of 667.8% 4Health News:Universal Health Services, Inc. Announces Sale of Acute Care Hospital and Addition of Two Behavioral Health Hospitals 2Health News:Mylan to Offer $400 Million in Cash Convertible Notes 2Health News:Mylan to Offer $400 Million in Cash Convertible Notes 3Health News:Diet may eliminate spasms for infants with epilepsy 2
Remote Alpha Dock system for the DNA Engine line, allows, Alpha unit to function remotely (requires fan power supply)...
Reads single TrakMates tubes instantly, and drops decoded tube number instantly into any Windows application. System includes reader and Windows based software....
Round, height-adjustable, steel laboratory stools with small footprint for small spaces • Choose options like different height-adjustment mechanism or paint finish. • your choice of color...
... acrylic panels mounted on powder-coated ... a free-standing modular cleanroom that ... 3. Optional ceiling HEPA filter/fan ... configured to customer requirements. Negative-pressure ...
Medicine Products: